Drug
Rupatadine clinical trials
Includes 1 study of Rupatadine fumarate.
- studies test it
- 13
- open now
- 3
- in phase 3
- 3
- first study started
- 2002
Keep track of what changes. Save the rupatadine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
12 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
- Phase 3
- 3
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 5
J. Uriach and Company (6) · Noucor Health S.A. (2) · Charite University, Berlin, Germany (2) · Alexandria University (1) · Sherief Abd-Elsalam (1) · St. Paul's Sinus Centre (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses rupatadine is read from its arms, and is right about nine times in ten.
Testing it · 13
- Rupatadine in Patients With Ulcerative ColitisRecruitingPhase 2Alexandria UniversityNCT07064707Written as Rupatadine
- Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control ParticipantsRecruitingPhase 1Noucor Health S.A.NCT06708520Written as Rupatadine
- Effect of Some Drugs on Rheumatoid Arithritis ActivityRecruitingPhase 3Sherief Abd-ElsalamNCT03770923Written as Rupatadine
- Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.CompletedPhase 1Noucor Health S.A.NCT06736340Written as Rupatadine
- Allergic Rhinitis Combination Pharmacotherapy Efficacy StudyWithdrawnPhase 4St. Paul's Sinus CentreNCT04601324Written as Rupatadine
- A Comparative Study of Rupatadine 10 mg Tablets and Clarinex® 5 mg Tablets Under Fasting ConditionsCompletedPhase 1J. Uriach and CompanyNCT05356143Written as Rupatadine
- Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic UrticariaTerminatedPhase 2J. Uriach and CompanyNCT00199238Written as Rupatadine Fumarate
- Chronic Urticaria - Long Term Assessment of Effects of RupatadineTerminatedPhase 3Charite University, Berlin, GermanyNCT02358265Written as 10 mg Rupatadine
- Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold UrticariaCompletedPhase 2Charite University, Berlin, GermanyNCT01605487Written as Rupatadine
- Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving PerformanceTerminatedPhase 4J. Uriach and CompanyNCT00162786Written as Rupatadine
- Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic UrticariaTerminatedPhase 3J. Uriach and CompanyNCT00199251Written as RUPATADINE
- Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy VolunteersCompletedPhase 1J. Uriach and CompanyNCT00199225Written as Rupatadine
- Study With Rupatadine in Mosquito-Bite Allergic Adult SubjectsStatus unknownPhase 4J. Uriach and CompanyNCT00258141Written as Rupatadine
As the comparator · 1 — what is tested is compared with rupatadine
Codes
What other systems call rupatadine · ClinicalTrials.gg INT003955
- MeSH (NLM) C103639rupatadineOne source NLM
- UNII (FDA) 2AE8M83G3ERUPATADINEConfirmed FDA, NLM, Wikidata
- Wikidata Q423450rupatadineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73055RupatadineOne source FDA
- DrugBank DB11614One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C103639 | rupatadine | One source NLM |
| UNII (FDA) | 2AE8M83G3E | RUPATADINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q423450 | rupatadine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73055 | Rupatadine | One source FDA |
| DrugBank | DB11614 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.